BiotechTube
PainTEQ

PainTEQ

Tampa, United States· Est.
painteq.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

PainTEQ, founded in 2015 and headquartered in Tampa, Florida, is a private medical device company commercializing the LinQ SI joint stabilization system. The LinQ procedure is a minimally invasive, outpatient treatment that uses a single, biologically-based allograft implant to address pain from SI joint dysfunction, positioning it as an alternative to more invasive fusion surgeries involving metal implants. The company targets the significant and often underserved market of chronic lower back pain patients where SI joint pathology is a contributor. PainTEQ appears to be in a commercial, revenue-generating stage, marketing its solution directly to physicians and patients.

MusculoskeletalPain Management

Technology Platform

Minimally invasive surgical implant system using a single, machined allograft designed for sacroiliac (SI) joint stabilization and biological fusion.

Opportunities

The large, often misdiagnosed population suffering from SI joint-derived chronic lower back pain represents a significant addressable market.
The shift towards outpatient, minimally invasive procedures and value-based care creates a favorable environment for the LinQ system's adoption.
PainTEQ can also leverage the growing awareness of SI joint pathology as a distinct condition to drive diagnosis and treatment.

Risk Factors

The company faces significant competition from larger medical device firms and alternative treatments.
Its dependence on a single product line creates concentrated business risk.
Securing and maintaining broad insurance reimbursement coverage for the procedure is critical and can be a lengthy, uncertain process.

Competitive Landscape

PainTEQ competes in the SI joint treatment market against conservative care (injections, physical therapy), radiofrequency ablation devices, and traditional SI joint fusion systems (often using metal implants) from major spine companies like Medtronic, SI-BONE (iFuse), and Globus Medical. Its key differentiation is the use of a biological allograft and a minimally invasive posterior approach marketed for faster recovery.

More companies in Digital Health & Biotech SaaS →More companies in United States →